Is the mid-term cure rate for testicular cancer very high?

Presumably, male patients will become very depressed after discovering that they have testicular cancer. In fact, everyone knows that many diseases are related to the patient's mental state. Therefore, patients do not need to worry too much. Actively treating the disease is the most important thing. The cure rate of testicular cancer is still very high. The high mid-term cure rate of testicular cancer also gives patients a lot of confidence.

The pathological type of testicular tumors is related to prognosis, and the extent of tumor spread and the range of metastasis also affect the prognosis. Therefore, clinicians should not only understand the pathological type of tumors, but also formulate corresponding treatment plans according to the different ranges of lesions.

The survival rate of patients with disseminated testicular germ cell cancer continues to improve, and the 3-year cancer-free overall survival rate has exceeded 80%. The cancer-free survival rate of patients with mild and moderate dissemination can reach more than 90%, but the survival rate of extensive dissemination cases is still less than 50%. Patients with mild and moderate dissemination of testicular cancer have a good prognosis. The current research focus is on how to reduce the toxicity of chemotherapy. The commonly used methods are to change 4 courses of chemotherapy to 3 courses or replace VLB with VP16, retain or cancel BLM, that is, replace the standard VPB regimen with PVP16 or PVP16B regimen, or replace DDP with carbon platinum (JM-8). The research direction of rescue chemotherapy for extensive disseminated testicular cancer is mainly to find new combination drugs for DDP (such as ifosfamide), new chemotherapy regimens and high-dose DDP combined chemotherapy.

Testicular cancer occurs in testicular tissue and has a complex pathological origin. It is relatively rare clinically, accounting for about 1% of all male malignant tumors. The affected population is mainly young men in their peak reproductive years. Therefore, it has a relatively large impact on society. However, the cure rate of testicular cancer is very high, with a survival rate of up to 95% or even higher. Therefore, in the field of oncology, testicular cancer is a very important malignant tumor.